Literature DB >> 21872871

Characterization of interaction kinetics between chiral solutes and human serum albumin by using high-performance affinity chromatography and peak profiling.

Zenghan Tong1, David S Hage.   

Abstract

Peak profiling and high-performance columns containing immobilized human serum albumin (HSA) were used to study the interaction kinetics of chiral solutes with this protein. This approach was tested using the phenytoin metabolites 5-(3-hydroxyphenyl)-5-phenylhydantoin (m-HPPH) and 5-(4-hydroxyphenyl)-5-phenylhydantoin (p-HPPH) as model analytes. HSA columns provided some resolution of the enantiomers for each phenytoin metabolite, which made it possible to simultaneously conduct kinetic studies on each chiral form. The dissociation rate constants for these interactions were determined by using both the single flow rate and multiple flow rate peak profiling methods. Corrections for non-specific interactions with the support were also considered. The final estimates obtained at pH 7.4 and 37°C for the dissociation rate constants of these interactions were 8.2-9.6 s(-1) for the two enantiomers of m-HPPH and 3.2-4.1 s(-1) for the enantiomers of p-HPPH. These rate constants agreed with previous values that have been reported for other drugs and solutes that have similar affinities and binding regions on HSA. The approach used in this report was not limited to phenytoin metabolites or HSA but could be applied to a variety of other chiral solutes and proteins. This method could also be adopted for use in the rapid screening of drug-protein interactions.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21872871      PMCID: PMC3172703          DOI: 10.1016/j.chroma.2011.08.026

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  24 in total

1.  Determination of drug-plasma protein binding kinetics and equilibria by chromatographic profiling: exemplification of the method using L-tryptophan and albumin.

Authors:  Ann M Talbert; George E Tranter; Elaine Holmes; Peter L Francis
Journal:  Anal Chem       Date:  2002-01-15       Impact factor: 6.986

2.  High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE.

Authors:  R L Rich; Y S Day; T A Morton; D G Myszka
Journal:  Anal Biochem       Date:  2001-09-15       Impact factor: 3.365

Review 3.  Practical aspects of the ligand-binding and enzymatic properties of human serum albumin.

Authors:  Ulrich Kragh-Hansen; Victor Tuan Giam Chuang; Masaki Otagiri
Journal:  Biol Pharm Bull       Date:  2002-06       Impact factor: 2.233

4.  Stereoselective kinetics of warfarin binding to human serum albumin: effect of an allosteric interaction.

Authors:  Ilona Fitos; Júlia Visy; Julianna Kardos
Journal:  Chirality       Date:  2002-05-15       Impact factor: 2.437

5.  Chromatographic analysis of carbamazepine binding to human serum albumin.

Authors:  Hee Seung Kim; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-02-25       Impact factor: 3.205

6.  Kinetic studies of drug-protein interactions by using peak profiling and high-performance affinity chromatography: examination of multi-site interactions of drugs with human serum albumin columns.

Authors:  Zenghan Tong; John E Schiel; Efthimia Papastavros; Corey M Ohnmacht; Quentin R Smith; David S Hage
Journal:  J Chromatogr A       Date:  2010-10-23       Impact factor: 4.759

Review 7.  Characterization of drug interactions with serum proteins by using high-performance affinity chromatography.

Authors:  David S Hage; Jeanethe Anguizola; Omar Barnaby; Abby Jackson; Michelle J Yoo; Efthimia Papastavros; Erika Pfaunmiller; Matt Sobansky; Zenghan Tong
Journal:  Curr Drug Metab       Date:  2011-05       Impact factor: 3.731

Review 8.  Allosteric modulation of drug binding to human serum albumin.

Authors:  Paolo Ascenzi; Alessio Bocedi; Stefania Notari; Gabriella Fanali; Riccardo Fesce; Mauro Fasano
Journal:  Mini Rev Med Chem       Date:  2006-04       Impact factor: 3.862

Review 9.  Kinetic studies of biological interactions by affinity chromatography.

Authors:  John E Schiel; David S Hage
Journal:  J Sep Sci       Date:  2009-05       Impact factor: 3.645

10.  Measurement of drug-protein dissociation rates by high-performance affinity chromatography and peak profiling.

Authors:  John E Schiel; Corey M Ohnmacht; David S Hage
Journal:  Anal Chem       Date:  2009-06-01       Impact factor: 6.986

View more
  14 in total

Review 1.  Pharmaceutical and biomedical applications of affinity chromatography: recent trends and developments.

Authors:  David S Hage; Jeanethe A Anguizola; Cong Bi; Rong Li; Ryan Matsuda; Efthimia Papastavros; Erika Pfaunmiller; John Vargas; Xiwei Zheng
Journal:  J Pharm Biomed Anal       Date:  2012-01-14       Impact factor: 3.935

Review 2.  Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents.

Authors:  Daniel Gonzalez; Stephan Schmidt; Hartmut Derendorf
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

Review 3.  Analysis of stereoselective drug interactions with serum proteins by high-performance affinity chromatography: A historical perspective.

Authors:  Zhao Li; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2017-01-11       Impact factor: 3.935

Review 4.  Kinetic analysis of drug-protein interactions by affinity chromatography.

Authors:  Cong Bi; Sandya Beeram; Zhao Li; Xiwei Zheng; David S Hage
Journal:  Drug Discov Today Technol       Date:  2015-10-08

5.  Optimization of human serum albumin monoliths for chiral separations and high-performance affinity chromatography.

Authors:  Erika L Pfaunmiller; Mahli Hartmann; Courtney M Dupper; Sony Soman; David S Hage
Journal:  J Chromatogr A       Date:  2012-09-10       Impact factor: 4.759

Review 6.  Analytical methods for kinetic studies of biological interactions: A review.

Authors:  Xiwei Zheng; Cong Bi; Zhao Li; Maria Podariu; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2015-01-27       Impact factor: 3.935

Review 7.  Investigating metabolite-protein interactions: an overview of available techniques.

Authors:  Grace Xiaolu Yang; Xiyan Li; Michael Snyder
Journal:  Methods       Date:  2012-06-28       Impact factor: 3.608

Review 8.  Analysis of Biological Interactions by Affinity Chromatography: Clinical and Pharmaceutical Applications.

Authors:  David S Hage
Journal:  Clin Chem       Date:  2017-04-10       Impact factor: 8.327

Review 9.  Studies of metabolite-protein interactions: a review.

Authors:  Ryan Matsuda; Cong Bi; Jeanethe Anguizola; Matthew Sobansky; Elliott Rodriguez; John Vargas Badilla; Xiwei Zheng; Benjamin Hage; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-11-25       Impact factor: 3.205

Review 10.  Analysis of biomolecular interactions using affinity microcolumns: a review.

Authors:  Xiwei Zheng; Zhao Li; Sandya Beeram; Maria Podariu; Ryan Matsuda; Erika L Pfaunmiller; Christopher J White; NaTasha Carter; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-01-27       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.